Company intelligence / Profile preview

IDEX Corporation

Northbrook, Illinois, United Statesidexcorp.com ↗

Ownership: Public · IEX
Employees: ~8700
Development stage: Commercial

Overview

IDEX Corporation, through its Health & Science Technologies segment and Material Processing Technologies group, provides advanced fluidic, microfluidic, optical, and particle processing solutions used in pharmaceutical research, clinical diagnostics, bioprocessing/manufacturing of biologics including vaccines and gene therapies. Their products are widely adopted by instrument developers in life sciences for high precision sample handling and analysis. Recent innovations include the MP350 Microlyser™ processor for scalable cell disruption in biopharma production.

Modalities: Device
Industry: Non-Drug Biotech

Partnerships

Collaborates with major instrument manufacturers and biotech/pharma companies as an OEM supplier/partner

Financials

Market cap: $16.6B
Total revenue: $920.6M
Enterprise value: $17.9B

Beyond the preview

Go deeper on IDEX Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IDEX Corporation.

Explore the full profile